With more than three decades spent at the crossroads of pharmacology and dental hygiene, I have watched the same story unfold again and again. A little-known botanical suddenly finds itself at the center of the wellness conversation, praised for doing what expensive prescription drugs do, only “naturally.” Right now, that botanical is berberine.

If you spend any time on social media, you have likely seen berberine crowned as “nature’s Ozempic,” a plant-based shortcut to weight loss, steadier blood sugar, and better metabolic health. The comparison is catchy, and it has helped propel berberine from an obscure supplement into one of the most searched-for products in the wellness aisle. But as is so often the case, the marketing and the pharmacology are telling two very different stories.

What is berberine?

Berberine is not new, and it is not fringe. It is a bright-yellow alkaloid found in several plants, including goldenseal, barberry, and Oregon grape, and it has been used in traditional medicine systems for centuries.¹ Modern research has focused largely on its effects on blood sugar and lipids, and there is a legitimate signal there. Berberine appears to modestly improve glucose regulation and some cardiometabolic markers, which is precisely why it attracts comparisons to prescription metabolic drugs.²

“Nature’s Ozempic”?

The problem is the “Ozempic” part. Semaglutide and other GLP-1/GIP receptor agonists have been studied in large, long-term trials demonstrating meaningful weight loss and reductions in cardiovascular events. Berberine has not. The National Center for Complementary and Integrative Health notes that the human weight-loss data are limited, inconsistent, and drawn largely from studies conducted outside North America, with many carrying a high risk of bias.³ Calling berberine “nature’s Ozempic” is not a scientific claim; it is a marketing one.

Why should this matter to the dental hygienist?

So, why is this relevant to the dental hygienist? Well, it has almost nothing to do with weight loss. Berberine is a potent inhibitor of the cytochrome P450 enzyme system, the metabolic machinery responsible for processing a large share of the medications our patients take.

In a controlled human study, two weeks of berberine reduced the activity of CYP2D6, CYP2C9, and CYP3A4, enzymes collectively involved in metabolizing a substantial majority of prescription drugs.⁴ When these enzymes are slowed, drug levels in the bloodstream can climb, sometimes into the range where side effects or toxicity become a concern.

For dentistry, one finding stands out. In that same human study, two weeks of berberine reduced CYP2D6 activity roughly ninefold.⁴ That enzyme matters more than its name suggests. Codeine, a common component of postoperative pain management, is itself inactive; it relies on CYP2D6 to convert into morphine, the form that actually relieves pain. When berberine blunts that enzyme, a patient may convert far less codeine into its active form and get little relief from a standard dose.

Tramadol, another analgesic used for dental pain, depends on the same pathway. A patient who has quietly added a berberine supplement to their routine could, in theory, find their pain medication underperforming, and nothing on their medication list would explain why.

The interaction list does not stop there. Because berberine itself lowers blood glucose, it can compound the effects of diabetes medications such as metformin, sulfonylureas, and insulin, raising the possibility of hypoglycemia.³ It has also been shown to raise blood levels of cyclosporine, an immunosuppressant, in transplant patients.⁵ These are not exotic scenarios; they involve medications our patients take every day.

Berberine presents a particularly interesting wrinkle for dental hygienists, because it does have genuine antimicrobial activity. Laboratory studies have shown berberine to be active against several oral pathogens, including Streptococcus mutans, Porphyromonas gingivalis, and Aggregatibacter actinomycetemcomitans, and small studies of berberine-containing rinses and gels have reported reductions in plaque and gingival inflammation.⁶

While that sounds like good news, it can also reinforce a patient’s belief that berberine is wholesome, harmless, and beneficial across the board, including in the mouth. The antimicrobial story and the drug-interaction story coexist, and a patient who has read about one may be entirely unaware of the other. Our role is not to talk anyone out of a dietary supplement, but to make sure the full pharmacologic picture is on the table.

Labels shape perception

As I noted in my recent article on kratom, one of the recurring themes in the world of herbal supplements is that labels often shape perception more than pharmacology does. Berberine is a textbook example. Patients see the words “natural,” “plant-based,” and “supplement” and reasonably conclude that the product may be “harmless.” Yet berberine is a pharmacologically active compound capable of altering how the body processes prescription medications.

Product variability also compounds the issue. Because dietary supplements are often not standardized, the amounts and formulations of berberine used across studies have varied widely, and commercial preparations can differ meaningfully in content, meaning two patients reporting that they use berberine may be taking very different doses.³ Add to that the mostly mild but common gastrointestinal effects—nausea, abdominal pain, bloating, constipation, and diarrhea—reported across clinical trials, and the picture of a “harmless” supplement becomes considerably more difficult to swallow (pardon the pun).³

None of this means berberine is dangerous, and it certainly does not mean every patient taking it is at risk. What it does mean is that berberine belongs in the same category of scrutiny and respect we extend to any substance capable of altering human physiology.

The medical history

As I have said many times, the three most important questions to ask any patient are: “What do you take?” “Why do you take it?” and “Did you take it today?” Notice that none of those questions uses the word “medication.” A patient who takes a daily berberine capsule for their metabolism may never think to mention it if we ask only about drugs and prescriptions. Broadening the question to include supplements, powders, and wellness products is often what surfaces the very information that matters most.

Editor’s note: This article first appeared in RDH eVillage newsletter, a publication of the Endeavor Business Media Dental Group. Read more articles and subscribe.

References

1. Neag MA, Mocan A, Echeverría J, et al. Berberine: botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders. Front Pharmacol. 2018;9:557. doi:10.3389/fphar.2018.00557
2. Och A, Och M, Nowak R, Podgórska D, Podgórski R. Berberine, a herbal metabolite in the metabolic syndrome: the risk factors, course, and consequences of the disease. Molecules. 2022;27(4):1351. doi:10.3390/molecules27041351
3. Berberine and weight loss: what you need to know. National Center for Complementary and Integrative Health. Updated November 2023. Accessed July 2026. https://www.nccih.nih.gov/health/berberine-and-weight-loss-what-you-need-to-know
4. Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012;68(2):213-217. doi:10.1007/s00228-011-1108-2
5. Wu X, Li Q, Xin H, Yu A, Zhong M. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. Eur J Clin Pharmacol. 2005;61(8):567-572. doi:10.1007/s00228-005-0952-3
6. Lee DG, Kim MJ, Park SN, et al. Antimicrobial activity of berberine against oral bacteria related to endodontic infections. Int J Oral Biol. 2013;38(4):141-147. doi:10.11620/IJOB.2013.38.4.141